| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |